Antitumor activity of a Schiff base copper(II) complex against triple-negative breast cancer via ferroptosis and autophagy pathways.
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking effective therapeutic targets and exhibiting poor response to conventional chemotherapy. Copper(II) complexes have emerged as promising anti-TNBC agents due to their multi-targeting antitumor activity. Here, we report that a Schiff base copper(II) co...